Zhicheng R Qiu1, Beate Schwer2, Stewart Shuman3. 1. Molecular Biology Program, Sloan-Kettering Institute, New York, New York 10065. 2. Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065 bschwer@med.cornell.edu s-shuman@ski.mskcc.org. 3. Molecular Biology Program, Sloan-Kettering Institute, New York, New York 10065 bschwer@med.cornell.edu s-shuman@ski.mskcc.org.
Abstract
The trimethylguanosine (TMG) caps of small nuclear (sn) RNAs are synthesized by the enzyme Tgs1 via sequential methyl additions to the N2 atom of the m(7)G cap. Whereas TMG caps are inessential for Saccharomyces cerevisiae vegetative growth at 25° to 37°, tgs1∆ cells that lack TMG caps fail to thrive at 18°. The cold-sensitive defect correlates with ectopic stoichiometric association of nuclear cap-binding complex (CBC) with the residual m(7)G cap of the U1 snRNA and is suppressed fully by Cbc2 mutations that weaken cap binding. Here, we show that normal growth of tgs1∆ cells at 18° is also restored by a C-terminal deletion of 77 amino acids from the Snp1 subunit of yeast U1 snRNP. These results underscore the U1 snRNP as a focal point for TMG cap function in vivo. Casting a broader net, we conducted a dosage suppressor screen for genes that allowed survival of tgs1∆ cells at 18°. We thereby recovered RPO26 (encoding a shared subunit of all three nuclear RNA polymerases) and RPO31 (encoding the largest subunit of RNA polymerase III) as moderate and weak suppressors of tgs1∆ cold sensitivity, respectively. A structure-guided mutagenesis of Rpo26, using rpo26∆ complementation and tgs1∆ suppression as activity readouts, defined Rpo26-(78-155) as a minimized functional domain. Alanine scanning identified Glu89, Glu124, Arg135, and Arg136 as essential for rpo26∆ complementation. The E124A and R135A alleles retained tgs1∆ suppressor activity, thereby establishing a separation-of-function. These results illuminate the structure activity profile of an essential RNA polymerase component.
The trimethylguanosine (TMG) caps of small nuclear (sn) RNAs are synthesized by the enzyme Tgs1 via sequential methyl additions to the N2 atom of the m(7)G cap. Whereas TMG caps are inessential for Saccharomyces cerevisiae vegetative growth at 25° to 37°, tgs1∆ cells that lack TMG caps fail to thrive at 18°. The cold-sensitive defect correlates with ectopic stoichiometric association of nuclear cap-binding complex (CBC) with the residual m(7)G cap of the U1 snRNA and is suppressed fully by Cbc2 mutations that weaken cap binding. Here, we show that normal growth of tgs1∆ cells at 18° is also restored by a C-terminal deletion of 77 amino acids from the Snp1 subunit of yeastU1 snRNP. These results underscore the U1 snRNP as a focal point for TMG cap function in vivo. Casting a broader net, we conducted a dosage suppressor screen for genes that allowed survival of tgs1∆ cells at 18°. We thereby recovered RPO26 (encoding a shared subunit of all three nuclear RNA polymerases) and RPO31 (encoding the largest subunit of RNA polymerase III) as moderate and weak suppressors of tgs1∆ cold sensitivity, respectively. A structure-guided mutagenesis of Rpo26, using rpo26∆ complementation and tgs1∆ suppression as activity readouts, defined Rpo26-(78-155) as a minimized functional domain. Alanine scanning identified Glu89, Glu124, Arg135, and Arg136 as essential for rpo26∆ complementation. The E124A and R135A alleles retained tgs1∆ suppressor activity, thereby establishing a separation-of-function. These results illuminate the structure activity profile of an essential RNA polymerase component.
Trimethylguanosine (TMG) cap structures are characteristic of small nuclear (sn) RNAs, small nucleolar (sno) RNAs, and telomerase RNA. TMG is formed post-transcriptionally by the enzyme Tgs1, which catalyzes two successive methyl additions to the N2 atom of the m7G cap (Mouaikel ; Hausmann and Shuman 2005; Chang ). Whereas m7G caps are essential for the viability of eukaryal cells, TMG caps are not (Mouaikel ; Hausmann ). Saccharomyces cerevisiae and Schizosaccharomyces pombe ∆ cells have no detectable TMG caps on their snRNAs, snoRNAs, or telomerase RNA, signifying that there is no Tgs1-independent route to form TMG caps (Mouaikel ; Hausmann ; Gallardo ; Franke ; Simoes-Barbosa ). ∆ yeast cells display apparently normal steady-state snRNA levels (Mouaikel ; Hausmann ) and no overt aberrations in the RNA or protein contents of their spliceosomal snRNPs, except for the acquisition of the nuclear cap-binding complex (CBC) as a stoichiometric component of the U1 snRNP (Schwer ).S. cerevisiae can grow in the absence of Tgs1 because the effects of ablating the TMG cap of the spliceosomal U snRNAs are genetically buffered, either by spliceosome assembly factors that are themselves inessential for vegetative growth (Hausmann ; Wilmes ; Chang ) or by otherwise dispensable domains of the essential branchpoint binding protein Msl5 (Chang ). Nonetheless, there are two situations in which the lack of TMG caps per se elicits a profound phenotype. First, S. cerevisiae ∆ diploids are unable to properly execute meiosis and sporulation because they are defective in splicing certain meiotic pre-mRNAs (Qiu ). Second, although S. cerevisiae haploid ∆ cells grow normally at 30°–37°, they are unable to grow at 18°–20° (Mouaikel ; Hausmann ), signifying that one or more essential cellular transactions becomes reliant on TMG caps at low temperatures.To gain insights to the basis for ∆ cold sensitivity, we sought to identify genetic suppressors that restore the growth of ∆ cells at restrictive temperature . Based on our findings that the residual m7G cap of the U1 snRNP in ∆ cells is accessible to and occupied by nuclear CBC, we queried whether mutating the cap-binding site of CBC (in the Cbc2 subunit of yeastCBC) might suppress ∆ cs growth. We thereby identified a series of hypomorphic mutations of Cbc2 predicted to weaken cap-binding (Mazza ; Calero ), which had no effect on vegetative growth in cells yet restored the growth of ∆ cells at 18°–20° (Schwer ; Qiu ) . We inferred from these results that the cs phenotype is caused, at least in part, by the ectopic association of nuclear CBP with the m7G cap of U1 snRNA.This focused our attention on the U1 snRNP as a potential source of additional ∆ suppressors. YeastU1 snRNP consists of a 568-nt U1 snRNA, a 7-subunit Sm protein ring, and 10 U1-specific snRNP subunits: Prp39, Prp40, Snu71, Snu56, Luc7, Prp42, Nam8, Snp1, Mud1, and Yhc1 (Gottschalk ; Schwer ). The Nam8 and Mud1 subunits are inessential for vegetative growth. Rather than suppressing ∆, we learned early on that ∆ and ∆ deletions were synthetic lethal with ∆ (Hausmann ). The essential Yhc1 subunit (the yeast homolog of humanU1-C) interacts directly with the conserved U1 snRNA 5′ leader sequence m2,2,7GpppAUACUUACCU that base-pairs to the complementary sequence of the consensus yeast 5′ splice site (GUAUGU) (Kondo ). Extensive mutagenesis of Yhc1, by C-terminal truncation and structure-guided alanine scanning, has yielded a collection of hypomorphic alleles that have no effect per se on vegetative growth, but have strong negative genetic interactions with Mud1, Nam8, and Mud2 (Schwer and Shuman 2014, 2015). Testing the mutant collection for interactions with ∆ uncovered many instances of synthetic lethality and sickness, but no case in which the ∆ cs phenotype was suppressed. The same was true of a series of truncation and alanine mutants of the SmD3 and SmB subunits of the yeast Sm ring (Schwer and Shuman 2015).Despite these discouraging results, we continued the search for ∆ suppressors along two lines, one U1-centric, and one unbiased. As we report here, both approaches bore fruit. In the first instance, we generated a series of viable truncation mutants of U1 subunit Snp1 and screened them for genetic interactions. We found two C-terminal truncations of Snp1 that restored the growth of ∆ cell at low temperature.In parallel, we screened a 2-µ plasmid-based yeast genomic library for candidate dosage suppressors of the ∆ cs defect. The rationale was that bypass by overexpression might identify specific gene products or cellular transactions that are limiting when TMG caps are absent. We report the results of the screen, which identified the RNA polymerase subunit Rpo26 as capable of reviving the growth of ∆ cells at restrictive temperature when expressed from plasmid vectors. Rpo26, a 155-aa polypeptide, is an essential constituent of all three nuclear RNA polymerases (Pol I, Pol II, and Pol III) (Archambault ; Woychik ). Rpo26 plays key roles in nuclear RNA polymerase assembly and function (Nouraini ; Tan ). It makes direct atomic contacts to the catalytic Rpo21 subunit of yeast Pol II (Cramer ), and hypomorphic mutations of Rpo26 are synthetic lethal in combination with an allele (Archambault ; Nouraini ). Rpo26 interacts similarly with the catalytic Rpa190 subunit in the crystal structure of yeast Pol I (Fernández-Tornero ) and is presumed to do so with the catalytic Rpo31 subunit of Pol III. Our screen also identified Rpo31 as a weaker ∆ suppressor.We proceeded to conduct a structure-guided mutational analysis of Rpo26 and thereby delineated a minimal functional domain, Rpo26-(78-155), capable of ∆ complementation and ∆ cs suppression. We identified separation-of-function mutations within this domain that abolished ∆ complementation without affecting ∆ suppression.
Materials and Methods
Snp1 C-terminal truncations and tests of function
A 1.59-kbp DNA segment bearing the gene (nucleotides −400 to +1190) was amplified from S. cerevisiae genomic DNA by PCR using primers that introduced restriction sites for inserting the gene into the yeast expression plasmids pRS316 (CEN ) and pRS413 (CEN ). The resulting plasmids p316-SNP1 and p413-SNP1 were constructed to introduce a 5′ BamHI site and a 3′ SpeI site immediately flanking the open reading frame. C-terminal truncation alleles , , and were generated by PCR amplification with reverse primers that introduced a STOP codon in lieu of codons for Thr224, Ser209, or Phe194 and a flanking SpeI site. The mutated PCR fragments were digested and inserted into p413-SNP1 in lieu of the wild-type gene. The plasmid-borne genes were sequenced completely to confirm that no unwanted changes were introduced during PCR and cloning.To assess the effects of mutations, we first generated a haploid ∆ [p316-SNP1] strain by sporulating and dissecting heterozygous ::kanMX diploids (Open Biosystems) that had been transfected with p316-SNP1. ∆ [p316-SNP1] cells were resistant to G418 and unable to grow on medium containing 5-fluoroorotic acid (FOA). To assess the function of alleles, ∆ [p316-SNP1] cells were transfected with p413-SNP1 () plasmids. His+ transformants were selected and streaked on agar medium containing FOA. The plates were incubated at 20°, 30°, and 37°, and mutants that failed to form colonies at any temperature after 8 d were deemed lethal. Individual FOA-resistant colonies of viable alleles were grown to mid-log phase in YPD broth and adjusted to A600 of 0.1. Aliquots (3 µl) of serial 10-fold dilutions were spotted to YPD agar plates, which were then incubated at temperatures ranging from 18° to 37°. We also developed plasmid shuffle assays to test mutational effects on function in ∆, ∆, ∆, ∆, and cells using standard genetic manipulations of mating, sporulation, and dissection.
Screen for dosage suppressors of tgs1Δ cold sensitivity
∆ cells were transfected with a yeast genomic DNA library in vector YEp24 (2 μ ). Approximately 41,000 Ura+ transformants were plated on medium lacking uracil at 18°. The 2 μ plasmid was isolated from 20 colonies that grew at 18° and then transformed into Escherichia coli. Plasmids were prepared from cultures of individual ampicillin-resistant transformants. The 20 candidate suppressor plasmids were re-tested by transformation into the ∆ strain; 16 of them rescued growth of ∆ cells at 18°. Primers flanking the cloning site were used to sequence the ends of the genomic DNA inserts in these 16 plasmids and thereby identify the genes contained in each clone. Eight of the clones contained the gene. Six plasmids contained a yeast genomic DNA locus, provisionally named DTS1 (DTS = deletion of suppressor). Two plasmids contained a different yeast genomic locus, provisionally named DTS2.
Yeast expression plasmids
The following DNA fragments with flanking BamHI sites at both 5′ and 3′ ends were amplified by PCR using DTS1 or DTS2 plasmids as templates: (i) the ORF and intron (544 bp) plus 419 bp and 239 bp of 5′ and 3′ flanking genomic DNA; (ii) the ORF (492 bp) plus 443 bp and 240 bp of 5′ and 3′ flanking genomic DNA; (iii) the ORF (1.3 kbp) plus 455 bp and 244 bp of 5′ and 3′ flanking genomic DNA; (iv) the ORF (3.0 kbp) plus 442 bp and 231 bp of 5′ and 3′ flanking genomic DNA; (v) the ORF (2.7 kbp) plus 441 bp and 303 bp of 5′ and 3′ flanking genomic DNA; (vi) the ORF plus 463 bp and 276 bp of 5′ and 3′ flanking genomic DNA; and (vii) the ORF plus 475 bp and 232 bp of 5′ and 3′ flanking genomic DNA. A DNA fragment containing the ORF (4.4 kbp) plus 426 bp of upstream (5′) and 230 bp of downstream (3′) chromosomal DNA was amplified by PCR from the DTS2 plasmid using primers that introduced SalI sites at both the 5′ and 3′ ends. The intron was removed cleanly from its genomic fragment via two-stage overlap extension PCR to generate the cDNA () with its genomic DNA flanks and BamHI terminal restriction sites. The PCR products were then restricted at the terminal sites and inserted into yeast expression vector YEp24 (2 μ ). The restricted fragments of , , and were also inserted into yeast expression vector pRS415 (CEN ). was inserted into BamHI-cut pRS316 (CEN ) to yield pRS316-RPO26 for use in the plasmid shuffle assays described below. The plasmid inserts were sequenced completely to exclude the acquisition of unwanted changes during PCR amplification and cloning. Plasmids p360-TGS1 (CEN ) and pUN100-TGS1 (CEN ) used as positive controls were described previously (Hausmann ).
Rpo26 mutants
An intron-less ORF was PCR-amplified with sense-strand primers designed to introduce a BamHI restriction site immediately upstream of the translation start codon and an antisense primer that introduced an XhoI site downstream of the stop codon. The PCR product was digested with BamHI and XhoI and then inserted into a yeast expression vector pRS425-TPI (2 μ ) to yield pRS425-TPI-RPO26, in which expression of is driven by the yeast promoter, contained in a 2.2-kb PvuII fragment from pYX132 (Novagen).Truncated alleles were constructed by PCR amplification with: (i) sense strand primers that introduced a new start codon at the positions specified plus a flanking BamHI site and/or (ii) antisense strand primers that introduced a new stop codon after the positions specified plus a flanking XhoI site. Single-alanine mutations R79A, E89A, R97A, E124A, R135A, R136A, D145A, and E150A were introduced into by two-stage PCR overlap extension with mutagenic primer oligonucleotides. The PCR products containing the mutated ORFs were digested with BamHI and XhoI and inserted into BamHI/XhoI-cut pRS425-TPI-RPO26 in lieu of the wild-type gene. The inserts of all plasmid clones were sequenced to exclude the acquisition of unwanted mutations during amplification and cloning.
Plasmid shuffle assay for rpo26Δ complementation
A heterozygous diploid S. cerevisiae ::kanMX heterozygous strain (purchased from Open Biosystems) was transformed with pRS316-RPO26. The resulting Ura+ diploid was sporulated and tetrads were dissected. We thereby recovered viable ::kanMX haploids that were resistant to G418 and unable to grow on medium containing 0.75 mg/ml FOA (5-fluoroorotic acid), a drug that selects against the plasmid. The Δ strain was used to test plasmid-borne alleles of for Δ complementation by plasmid shuffle as follows. pRS316-RPO26 cells were transfected with pRS425-TPI-RPO26 plasmids containing wild-type or mutant alleles. Individual transformants were selected and patched on SD-Leuagar medium. Cells from each isolate were streaked on agar medium containing 1.0 mg/ml FOA at 30°. In cases where the -containing plasmid supported growth on FOA, two isolates of each mutant amplified from single FOA-resistant colonies were tested for growth by spotting 3-μl aliquots of serial 10-fold dilutions of cells (from liquid cultures grown in SD–Leu medium to mid-log phase at 30° and adjusted to A600 of 0.1) to YPD agar and incubating the plates at 18° for 7 d, 25° for 4 d, 30° for 3 d, or 37° for 2 d.
Results
Synthetic genetics of Snp1 truncation mutants
Snp1, a 300-aa polypeptide, is the yeast homolog of humanU1-70K (437-aa). Alignment of their primary structures highlights 98 positions of side-chain identity/similarity over the N-terminal 207-aa segment of Snp1 (Figure 1A). In the 3.3 Å crystal structure of the core humanU1 snRNP (Kondo ), the N-terminal 60-aa segment of U1-70K is a highly extended polypeptide that drapes across the surface of the U1 particle, making contacts to U1-C/Yhc1 near the U1 snRNA 5′ terminus, to each of the Sm ring subunits, and to the U1 snRNA 3′ of the Sm site. The segment of U1-70K from aa 61-202 (underlined in Figure 1A), comprising a long α helix and an RRM domain, binds to the conserved stem-loop 1 (SL1) of the U1 snRNA (Kondo ). The C-terminal domains of Snp1 and U1-70K differ in length and amino acid sequence and are expected to be poorly structured based on their amino acid composition. The conserved N-terminal 21-aa peptide of Snp1 that interacts with U1-C/Yhc1 and SmD3 could be deleted without effect on yeast vegetative growth at any temperature (Schwer and Shuman 2015). A ∆ double-mutant displayed the same cs growth defect as ∆ (Schwer and Shuman 2015).
Figure 1
Snp1 C-terminal truncations suppress tgs1∆ cold sensitivity. (A) The amino acid sequence of the 300-aa S. cerevisiae Snp1 protein is aligned to the homologous segment of the 437-aa human U1-70K polypeptide. Positions of side chain identity/similarity are indicated by • above the alignment. Arrowheads indicate the boundaries of the C-terminal truncations of Snp1. (B) The wild-type and truncated SNP1 alleles were tested for activity by plasmid shuffle in snp1∆, snp1∆ mud2∆, snp1∆ nam8∆, snp1∆ mud1∆, and snp1∆ tgs1∆ strains. Viable FOA-resistant snp1∆ strains bearing the indicated SNP1 allele on a CEN HIS3 plasmid in an otherwise wild-type (top panel), mud1∆, or nam8∆ background as indicated were spot-tested for growth on YPD agar at the temperatures specified. Synthetic growth defects are denoted by •. snp1∆ tgs1∆ strains bearing the indicated SNP1 allele on a CEN HIS3 plasmid were spot-tested for growth on YPD agar at the temperatures specified (bottom panel). Suppressors of the tgs1∆ cs phenotype are denoted by arrowheads.
Snp1 C-terminal truncations suppress tgs1∆ cold sensitivity. (A) The amino acid sequence of the 300-aa S. cerevisiaeSnp1 protein is aligned to the homologous segment of the 437-aa humanU1-70K polypeptide. Positions of side chain identity/similarity are indicated by • above the alignment. Arrowheads indicate the boundaries of the C-terminal truncations of Snp1. (B) The wild-type and truncated SNP1 alleles were tested for activity by plasmid shuffle in snp1∆, snp1∆ mud2∆, snp1∆ nam8∆, snp1∆ mud1∆, and snp1∆ tgs1∆ strains. Viable FOA-resistant snp1∆ strains bearing the indicated SNP1 allele on a CEN HIS3 plasmid in an otherwise wild-type (top panel), mud1∆, or nam8∆ background as indicated were spot-tested for growth on YPD agar at the temperatures specified. Synthetic growth defects are denoted by •. snp1∆ tgs1∆ strains bearing the indicated SNP1 allele on a CEN HIS3 plasmid were spot-tested for growth on YPD agar at the temperatures specified (bottom panel). Suppressors of the tgs1∆ cs phenotype are denoted by arrowheads.Here, we constructed three C-terminal truncation mutants of Snp1 with distal margins indicated by the reverse arrowheads in Figure 1A. The wild-type and truncated alleles were placed on CEN plasmids under the control of the native promoter and tested by plasmid shuffle for complementation of a ∆ p[CEN ] strain. The resulting , , and strains were viable after FOA selection and grew as well as wild-type cells on YPD agar (Figure 1B).We surveyed genetic interactions of the benign Snp1 C-terminal truncations with ∆, ∆, and ∆. The results (Figure 1B) disclosed an informative hierarchy of synthetic mutational effects. , , and were lethal at all temperatures in the absence of Mud2, indicating that the essential contributions of the Snp1 segment downstream of the RRM module to early spliceosome assembly/stability are buffered by the cross-intron bridging interactions of Mud2 (engaged with Msl5 at the branchpoint) with U1 snRNP at the 5′ splice site.and were barely viable in the ∆ genetic background and was synthetically lethal with ∆. By contrast, and supported normal growth of ∆ cells at 20°–34° and slightly slowed growth at 37° (Figure 1B). The salient finding was that the more truncated allele was synthetically lethal in the ∆ strain, signifying that the Snp1 peptide 194FKPRRLGGGLGGRGY208 is critical for U1 snRNP function in vivo in the absence of Mud1. The corresponding peptide in U1-70K makes direct contacts to the SL1 loop (Kondo ).
SNP1-(1-223) and SNP1-(1-208) suppress tgs1Δ
The standout finding was that the and truncation alleles restored the growth of ∆ cells at 25° and 20° (Figure 1B) and at 18° (not shown). Colony size of the ∆ and ∆ strains on YPD medium at cold temperatures was indistinguishable from the wild-type strain (Figure 1B). Thus, deletion of the Snp1 segment from aa 224-300, downstream of the RRM domain, elicited a gain-of-function for the U1 snRNP that lacks a TMG cap. This positive genetic interaction was severed when the C-terminal truncation was extended into the RRM domain, i.e., the ∆ reverted to cs growth (à la ∆) and acquired a new ts phenotype (Figure 1B).
Mutational synergy of SNP1-(1-223) and SNP1-(1-208) with CBC2-Y24A
The Y24A mutation in the m7G-binding pocket of Cbc2 suppresses the ∆ cs growth defect (Qiu ), as do C-terminal truncations 1-223 and 1-208 of the U1 snRNP subunit Snp1. To query potential connections between Cbc2 and Snp1, we tested by plasmid shuffle the effects of the and alleles in ∆ and ∆ strain backgrounds. We also tested in parallel the N-terminal truncation allele , which eliminates a conserved peptide segment of Snp1/U1-70K that makes atomic contacts to the SmD3 and Yhc1/U1-C subunits of the U1 snRNP (Kondo ; Schwer and Shuman 2015). Whereas caused no apparent growth defect in the background, both and elicited a severe cold-sensitive defect in cells (Figure 2), one that recapitulates the cold-sensitive growth defect of a ∆ null strain (Qiu ).
Figure 2
Mutational synergy of SNP1-(1-223) and SNP1-(1-208) with CBC2-Y24A. The wild-type and truncated SNP1 alleles were tested for activity by plasmid shuffle in CBC2 snp1∆ and CBC2-Y24A snp1∆ strains. FOA-resistant isolates were spot-tested for growth on YPD agar at the temperatures specified. Synthetic growth defects are denoted by •.
Mutational synergy of SNP1-(1-223) and SNP1-(1-208) with CBC2-Y24A. The wild-type and truncated SNP1 alleles were tested for activity by plasmid shuffle in CBC2snp1∆ and CBC2-Y24Asnp1∆ strains. FOA-resistant isolates were spot-tested for growth on YPD agar at the temperatures specified. Synthetic growth defects are denoted by •.
RPO26 and RPO31 are dosage suppressors of tgs1Δ cs growth
The dosage suppressor screen entailed transformation of S. cerevisiae ∆ cells with a 2-μ plasmid-based wild-type genomic DNA library and selection for Ura+ colonies that grew at 18°. Plasmid DNA was recovered from individual yeast colonies grown at 18° and then transformed into E. coli. Candidate suppressors were retransformed into the original ∆ strain and tested for growth at 18°. Sequencing the insert junctions of the plasmids that retested faithfully revealed that the rescuing clones contained either (as was to be expected) or one of two distinct extragenic suppressor loci, which we provisionally named DTS1 and DTS2, respectively (DTS = deletion of suppressor). Note that whereas the 2-µ DTS1 or 2-µ DTS2 plasmids restored growth at 18°, compared to ∆ cells carrying the empty 2-µ vector, neither 2-µ DTS1 nor 2-µ DTS2 was as effective as a plasmid, as gauged by colony size (Figure 3).
Figure 3
RPO26 and RPO31 are dosage suppressors of tgs1Δ cold sensitivity. DTS1 (8.6 kb) and DTS2 (12.4 kb) are the two genomic inserts in the 2-μ URA3 plasmids that were isolated in the dosage suppressor screen for reversal of tgs1Δ cs growth. Individual genes with complete ORFs within the DTS1 and DTS2 inserts including PZF1, RPO26, MLC2, SKI3, AZF1, RPO31, TRS33, and YOR114w were cloned into a 2-μ URA3 vector. These plasmids, an empty CEN URA3 vector (negative control), a CEN URA3 plasmid containing wild-type TGS1 (positive control), and the plasmids containing DTS1 or DTS2 were transformed into tgs1Δ cells. Ura+ transformants were selected and grown at 30° in liquid medium lacking uracil. The cultures were adjusted to an A600 of 0.1 and aliquots of serial 10-fold dilutions were spotted on agar medium lacking uracil. The plates were photographed after incubation for 7 d at 18°.
RPO26 and RPO31 are dosage suppressors of tgs1Δ cold sensitivity. DTS1 (8.6 kb) and DTS2 (12.4 kb) are the two genomic inserts in the 2-μ URA3 plasmids that were isolated in the dosage suppressor screen for reversal of tgs1Δ cs growth. Individual genes with complete ORFs within the DTS1 and DTS2 inserts including PZF1, RPO26, MLC2, SKI3, AZF1, RPO31, TRS33, and YOR114w were cloned into a 2-μ URA3 vector. These plasmids, an empty CEN URA3 vector (negative control), a CEN URA3 plasmid containing wild-type TGS1 (positive control), and the plasmids containing DTS1 or DTS2 were transformed into tgs1Δ cells. Ura+ transformants were selected and grown at 30° in liquid medium lacking uracil. The cultures were adjusted to an A600 of 0.1 and aliquots of serial 10-fold dilutions were spotted on agar medium lacking uracil. The plates were photographed after incubation for 7 d at 18°.
Defining the suppressor loci within the 2µ DTS1 and DTS2 plasmids
DTS1 spans a segment of chromosome XVI that includes four complete genes—, , , and —plus a 3′ fragment of the gene (Figure 3, top panel). To map the suppressor, we constructed a series of 2-µ vectors containing the individual , , , and open reading frames and ∼200–400 bp of 5′ and 3′ flanking genomic DNA. ∆ cells transformed with these plasmids were tested for growth at 18°, thereby revealing that the suppressor activity was inherent to (Figure 3, top panel), the yeast gene encoding a shared 155-amino acid subunit of nuclear RNA polymerases I, II, and III.DTS2 comprises a region of chromosome XV that embraces the complete , , , and genes, plus a 3′ fragment of the gene (Figure 3, bottom panel). When 2-µ vectors containing the individual , , , and open reading frames and ∼200–400 bp of 5′ and 3′ flanking genomic DNA were transformed into ∆ cells, only revived growth at 18° compared to the vector control (Figure 3, bottom panel). Rpo31 encodes the 1460-amino acid largest subunit of nuclear RNA polymerase III. Side-by-side comparison of the growth of ∆ cells bearing 2-µ or plasmids revealed that was a better suppressor of the cold-sensitive defect, as gauged by colony size (Figure 3, bottom panel).
RPO26 and RPO31 suppress tgs1Δ at low gene dosage
The identification of two RNA polymerase subunits as dosage suppressors of ∆ suggested a novel connection between TMG caps and transcription. The connection via Rpo31 to RNA polymerase III, which is responsible for the synthesis of many essential noncoding RNAs (5S rRNA, U6 snRNA, tRNAs), was particularly puzzling insofar as none of the known Pol III transcripts have 5′ TMG (or m7G) caps. One scenario that might explain the genetic suppressor results is that the loss of TMG caps affects nucleolar architecture and function (Colau ) such that the assembly or activity of Pol III is compromised at cold temperature, and this defect can be overcome, in part, by overexpressing either or . If this is the case, then we might expect that simultaneously overexpressing and would afford better growth of ∆ cells at 18° than increasing the gene dosage of either gene alone. We tested this by introducing and on the same 2-µ plasmid, but observed no better rescue of ∆ growth in the cold than that afforded by 2-µ (data not shown). Another prediction of the above scenario is that ∆ suppression should require high gene dosage. To address this issue, we placed the and genes on CEN plasmids and transformed them into ∆ cells. The striking finding was that provision of or on a CEN plasmid was just as effective as the 2-µ or plasmids in restoring ∆ growth at restrictive temperature (Figure 4).
Figure 4
RPO26 and RPO31, at low gene dosage, are capable of restoring growth of tgs1Δ at 18°. (Left) Yeast tgs1Δ cells were transformed with a CEN URA3 plasmid bearing wild-type TGS1 (positive control), an empty 2-μ URA3 vector (negative control), and 2-μ URA3 plasmids expressing wild-type RPO26, intron-less RPO26 cDNA (RPO26*), or RPO31. Ura+ transformants were selected at 30° and then tested for growth at 18° by spotting serial 10-fold dilutions of liquid cultures (grown at 30° in SD–Ura medium) on Ura− agar plates. The plates were photographed after incubation for 7 d at 18°. (Right) Yeast tgs1Δ cells were transformed with a CEN LEU2 plasmid bearing wild-type TGS1 (positive control), an empty CEN LEU2 vector (negative control), and CEN LEU2 plasmids expressing wild-type RPO26, RPO26*, or RPO31. Leu+ transformants were selected at 30° and then tested for growth at 18° by spotting serial 10-fold dilutions of liquid cultures (grown at 30° in SD-Leu medium) on SD-Leu agar plates. The plates were photographed after incubation for 7 d at 18°.
RPO26 and RPO31, at low gene dosage, are capable of restoring growth of tgs1Δ at 18°. (Left) Yeasttgs1Δ cells were transformed with a CEN URA3 plasmid bearing wild-type TGS1 (positive control), an empty 2-μ URA3 vector (negative control), and 2-μ URA3 plasmids expressing wild-type RPO26, intron-less RPO26 cDNA (RPO26*), or RPO31. Ura+ transformants were selected at 30° and then tested for growth at 18° by spotting serial 10-fold dilutions of liquid cultures (grown at 30° in SD–Ura medium) on Ura− agar plates. The plates were photographed after incubation for 7 d at 18°. (Right) Yeasttgs1Δ cells were transformed with a CEN LEU2 plasmid bearing wild-type TGS1 (positive control), an empty CEN LEU2 vector (negative control), and CEN LEU2 plasmids expressing wild-type RPO26, RPO26*, or RPO31. Leu+ transformants were selected at 30° and then tested for growth at 18° by spotting serial 10-fold dilutions of liquid cultures (grown at 30° in SD-Leu medium) on SD-Leuagar plates. The plates were photographed after incubation for 7 d at 18°.The aforementioned results point toward an alternative explanation for ∆ suppression, whereby the lack of TMG caps selectively impacts the expression of and/or , such that even one extra copy of these genes allows for growth in the cold. seemed to us the more plausible target of such an effect, because: (i) TMG caps are certainly implicated genetically in pre-mRNA splicing; (ii) the gene contains an intron, whereas does not; and (iii) prior studies had shown that a 60% reduction in the level of mature mRNA (caused by a mutation in the promoter) resulted in a cold-sensitive growth defect (Nouraini ). We initially considered a scenario in which adequate Rpo26 expression might somehow require the presence of an intron in the pre-mRNA, akin to what has been described for the yeastSus1 and the intron-containing pre-mRNA (Cuenca-Bono ; Hossain ). In that case, we would expect that an intron-less cDNA version of would not be able to suppress ∆. However, we found that the cDNA (designated * in Figure 3) was just as effective as the native gene in promoting ∆ growth at 18°, whether delivered on a 2-µ vector or a CEN vector (Figure 4).
N- and C-terminal truncations of Rpo26 delineate a minimal functional domain
The crystal structure of yeast RNA polymerase II (Cramer ) revealed the fold of the C-terminal segment of Rpo26 from amino acids 72 to 155, which comprises two α-helices and a β-hairpin (Figure 5). The N-terminal 71-amino-acid segment was disordered in the Pol II structure. In the recent crystal structure of yeast Pol I, the N-terminal 54-amino-acid segment of Rpo26 was disordered and the segment from amino acids 55 to 71 comprised an α-helix (Fernández-Tornero ). A previous study had shown that deleting 42 amino acids from the N-terminus of Rpo26 did not affect the viability of yeast cells when the truncated allele was driven by the strong promoter in galactose-containing medium; however, deletion of 84 amino acids from the Rpo26 N-terminus was lethal (Nouraini ).
Figure 5
N- and C-terminal truncations of Rpo26 delineate a minimal functional domain for tgs1∆ suppression. (Left) Tertiary structure of Rpo26-(72-155), from the yeast Pol II crystal structure (pdb 1I3Q), with the N and C termini indicated. (Bottom right) The amino acid sequence of yeast Rpo26. The C-terminal segment visualized in the Pol II crystal structure is in black font; the disordered N-terminal segment is in red font. The margins of the N- and C-terminal truncations are denoted by forward and reverse arrows. For the N-terminal deletions, the arrows specify the residues that were mutated to methionine to initiate the truncated proteins. Black arrows denote the truncations that allow the mutants to restore tgs1Δ growth at 18°, whereas the gray arrows denote the truncations that disable tgs1∆ suppression. (Top right) tgs1Δ cells were transformed with a CEN LEU2 plasmid bearing wild-type TGS1 (positive control), an empty 2-μ LEU2 TPI1 vector (negative control), or 2-μ LEU2 TPI1-RPO26 plasmids bearing wild-type RPO26 or the indicated truncation mutants. Leu+ transformants were selected at 30° and then tested for growth at 18° by spotting serial 10-fold dilutions of liquid cultures (grown at 30° in SD-Leu medium) on SD-Leu agar plates. The plates were photographed after incubation for 7 d at 18°.
N- and C-terminal truncations of Rpo26 delineate a minimal functional domain for tgs1∆ suppression. (Left) Tertiary structure of Rpo26-(72-155), from the yeast Pol II crystal structure (pdb 1I3Q), with the N and C termini indicated. (Bottom right) The amino acid sequence of yeastRpo26. The C-terminal segment visualized in the Pol II crystal structure is in black font; the disordered N-terminal segment is in red font. The margins of the N- and C-terminal truncations are denoted by forward and reverse arrows. For the N-terminal deletions, the arrows specify the residues that were mutated to methionine to initiate the truncated proteins. Black arrows denote the truncations that allow the mutants to restore tgs1Δ growth at 18°, whereas the gray arrows denote the truncations that disable tgs1∆ suppression. (Top right) tgs1Δ cells were transformed with a CEN LEU2 plasmid bearing wild-type TGS1 (positive control), an empty 2-μ LEU2TPI1 vector (negative control), or 2-μ LEU2TPI1-RPO26 plasmids bearing wild-type RPO26 or the indicated truncation mutants. Leu+ transformants were selected at 30° and then tested for growth at 18° by spotting serial 10-fold dilutions of liquid cultures (grown at 30° in SD-Leu medium) on SD-Leuagar plates. The plates were photographed after incubation for 7 d at 18°.Here, we tested the effects of finer incremental N- and C-terminal truncations on the in vivo activity of Rpo26, using two genetic readouts of function: (i) dosage suppression of ∆ and (ii) complementation of ∆. The truncated alleles were placed on 2-µ plasmids under the control of the yeast promoter. The N-terminal deletion alleles , , and were as effective as in supporting ∆ growth at 18°, whereas , a truncated version encoding just the disordered N-terminal segment of Rpo26, had no salutary effect (Figure 5). The allele complemented ∆ in a plasmid shuffle assay. cells grew as well as wild-type yeast at 18°, 25°, 30°, and 37°, as gauged by colony size (Figure 6B). We conclude that the N-terminal 77 amino acids are dispensable for Rpo26 function as a subunit of the three nuclear RNA polymerases and as a suppressor of ∆. By contrast, was a feeble suppressor of ∆ at 18° (Figure 5) and was unable to complement ∆ in the plasmid shuffle assay (not shown), signifying that the 78QRATTP83 peptide is important for Rpo26 activity.
Figure 6
Structure-guided alanine scan of Rpo26. (A) Annotated structure of Rpo26 (from pdb 1I3Q) highlighting atomic interactions (dashed lines) of selected side chains and main chain atoms (depicted as stick models with beige carbons). Eight residues were targeted for alanine scanning: Arg79, Glu89, Arg97, Glu124, Arg135, Arg136, Asp145, and Glu150. The lethal RPO26-Ala alleles are indicated on the right. (B) rpo26∆ complementation. Yeast strain rpo26Δ p(URA3 CEN RPO26) was transformed with 2-μ LEU2 TPI1-RPO26 plasmids bearing wild-type RPO26, RPO26-(78-155), or the indicated RPO26-Ala mutants. Leu+ transformants were selected at 30° on agar medium containing 5-FOA (1.0 mg/ml) and aliquots of serial 10-fold dilutions of the strains with the specified genotypes were spotted on YPD agar medium. The plates were photographed after incubation for 2 d at 37°, 3 d at 30°, 5 d at 25°, or 7 d at 18°. (C) tgs1∆ suppression. tgs1Δ cells were transformed with a CEN LEU2 plasmid bearing wild-type TGS1 (positive control), an empty 2-μ LEU2 TPI1 vector (negative control), or 2-μ LEU2 TPI1-RPO26 plasmids bearing wild-type RPO26 or the indicated RPO26-Ala mutants. Leu+ transformants were selected at 30° and then tested for growth at 18° by spotting serial 10-fold dilutions of liquid cultures (grown at 30° in SD-Leu medium) on SD-Leu agar plates. The plates were photographed after incubation for 7 d at 18°.
Structure-guided alanine scan of Rpo26. (A) Annotated structure of Rpo26 (from pdb 1I3Q) highlighting atomic interactions (dashed lines) of selected side chains and main chain atoms (depicted as stick models with beige carbons). Eight residues were targeted for alanine scanning: Arg79, Glu89, Arg97, Glu124, Arg135, Arg136, Asp145, and Glu150. The lethal RPO26-Ala alleles are indicated on the right. (B) rpo26∆ complementation. Yeast strain rpo26Δ p(URA3 CEN RPO26) was transformed with 2-μ LEU2TPI1-RPO26 plasmids bearing wild-type RPO26, RPO26-(78-155), or the indicated RPO26-Ala mutants. Leu+ transformants were selected at 30° on agar medium containing 5-FOA (1.0 mg/ml) and aliquots of serial 10-fold dilutions of the strains with the specified genotypes were spotted on YPD agar medium. The plates were photographed after incubation for 2 d at 37°, 3 d at 30°, 5 d at 25°, or 7 d at 18°. (C) tgs1∆ suppression. tgs1Δ cells were transformed with a CEN LEU2 plasmid bearing wild-type TGS1 (positive control), an empty 2-μ LEU2TPI1 vector (negative control), or 2-μ LEU2TPI1-RPO26 plasmids bearing wild-type RPO26 or the indicated RPO26-Ala mutants. Leu+ transformants were selected at 30° and then tested for growth at 18° by spotting serial 10-fold dilutions of liquid cultures (grown at 30° in SD-Leu medium) on SD-Leuagar plates. The plates were photographed after incubation for 7 d at 18°.We then tested the effects of deleting 5 amino acids or 16 amino acids from the C-terminus of the biologically active Rpo26-(70-155) polypeptide. Whereas was able to support growth of ∆ cells at 18°, the allele was not (Figure 5). failed to complement ∆ (not shown). By contrast, did complement ∆, albeit with a conditional phenotype whereby cells grew well at 18° and 25°, formed small colonies at 30°, and failed to grow at 37° (Figure 6B). Thus, the decapeptide segment 141GSFEDWSVEE150 is necessary for Rpo21 function at warmer temperatures. Because a previous study had shown that a nonsense mutant allele encoding Rpo26-(1-145) was unable to complement ∆ (Nouraini ), we can surmise that the pentapeptide 146WSVEE150 contains features essential for Rpo26 activity in vivo.
Structure-guided alanine scan identifies amino acids essential for rpo26Δ complementation
The crystal structure of Rpo26 in the context of RNA polymerase II highlights a network of intramolecular side chain contacts entailing salt bridge, hydrogen bonding, and π-cation interactions (Figure 6A). Here, we performed a structure-guided alanine scan of eight residues that comprise this network: Arg79, Glu89, Arg97, Glu124, Arg135, Arg136, Asp145, and Glu150. The alanine mutations were introduced into the biologically active gene on 2-µ plasmids under the control of the promoter and tested for complementation of ∆ by plasmid shuffle. Four of the alanine mutations were lethal: E89A, E124A, R135A, and R136A. Three of the alanine mutants—R79A, D145A and E150A—were viable and grew as well as “wild-type” at 18°, 25°, 30°, and 37° (Figure 6B). R97A cells grew at 25° and 30° but displayed cs and ts defects, whereby they failed to grow at 18° and grew slowly at 37°, as gauged by colony size (Figure 6B). We interpret the mutational data in light of the crystal structure, as follows.Arg79 is located within the 78QRATTP83 hexapeptide defined as essential by our deletion analysis; Arg79 forms a salt bridge to Glu150 (Figure 6A), which is located within the essential C-terminal pentapeptide 146WSVEE150. Yet alanine mutation of either Arg79 or Glu150 was benign in vivo (Figure 6B), signifying that this salt bridge is dispensable and that one or more other constituents of the 78QRATTP83 and 146WSVEE150 peptides must be essential for Rpo26 function. In the case of the proximal peptide segment, we suspect that the key contributions are the hydrogen bonds of the main-chain Thr82 and Tyr84 carbonyls to the terminal guanidiniumnitrogens of the essential Arg136 side chain (Figure 6A). For the distal 146WSVEE150 peptide, the Trp146 side chain is the likely key constituent, insofar as Trp146 is the focus of an extensive interaction network; it forms a cation–π–cation sandwich between Arg79 and Arg136 (Figure 6A) and it donates a hydrogen bond from Nε to the Glu144-Oε1 atom.The essential Glu89 side chain, located in the first α-helix, forms a bidentate ion pair to the Nε and NH2 atoms of the essential Arg136 side chain, which is situated in the first β-strand (Figure 6A). Glu89 also receives a hydrogen bond to Oε1 from the main-chain amide of Thr86. We surmise that the Glu89-Arg136salt bridge and the atomic contacts that Glu89 and Arg136 make to the main-chain of the 82TPYMT86 peptide loop preceding the first α-helix are necessary for Rpo26 folding and function. A conservative R136K mutation in elicits a temperature-sensitive growth defect (Nouraini ).Arg135 and Asp145 are situated on the opposite face of the β-hairpin, where they form an interstrand salt bridge (Figure 6A). It was noteworthy that whereas subtracting the Asp145 side chain had no apparent impact on cell growth, the loss of Arg135 was lethal. Thus, the Asp-Argsalt bridge is not essential for Rpo26 activity. Arg135 forms a cation-π stack on Phe143 (Figure 6A), and we suspect that this cation-π interaction accounts for the essentiality of Arg135. Consistent with this idea, replacing Arg135 with lysine, which would, in principle, preserve the cation-π interaction, had no effect on yeast growth (Nouraini ).The essential Glu124 side chain participates in a network of ionic and hydrogen bond contacts involving the two α-helices and the connecting loop (Figure 6A). Glu124 (in α1) makes a bidentate salt bridge to Arg97 (in α1 and conditionally essential at 18°) and accepts a hydrogen bond from the main-chain amide of Phe108 (in the loop). Arg97, in turn, donates hydrogen bonds to Gln100 and the main-chain carbonyl of Pro106. It was shown previously that replacing Gln110 with arginine results in cold-sensitive and temperature-sensitive growth defects (Tan ).
Rpo26 mutations that separate rpo26Δ complementation and tgs1Δ suppression activities
As one might expect, the R79A, D145A, and E150A mutants that complemented ∆ at 18° were also active in suppressing ∆ (Figure 6C). Mutations E89A and R136A that unconditionally abolished ∆ complementation also eliminated ∆ suppression. The salient findings were that: (i) two other mutants, R135A and E124A, that were unconditionally defective in ∆ complementation retained ∆ suppressor activity and (ii) mutant R97A, which was inactive in ∆ complementation at 18°, nonetheless complemented ∆ growth at 18°. Thus, R135A, E124A, and R97A exemplify separation of function mutations that distinguish the global role of Rpo26 in transcription by all nuclear RNA polymerases from its particular ability to act as a dosage suppressor of the cold sensitivity of ∆ cells.
Discussion
The present study provides new genetic insights to the impact of the lack of TMG caps in budding yeast. Prior screening for synthetic lethal and sick ∆ interactions had drawn attention specifically to the U1 snRNP as a focal point for TMG cap function in vivo (Hausmann ). This idea was fortified by the findings that the only overt change in the composition of yeast spliceosomal snRNPs in ∆ cells was the gain of CBC as a stoichiometric component of the U1 snRNP, by virtue of its binding to the residual m7G cap on the U1 snRNA (Schwer ). In cells, CBC is loosely associated with the U1 snRNP at low sub-stoichiometric levels compared to the intrinsic U1 snRNP subunits (Schwer ). It is thought that CBC interacts with one or more of the U1 snRNP proteins to facilitate bridging interactions between CBC bound to the pre-mRNA m7G cap and the U1 snRNP at the 5′ splice site (Lewis ; Görnemann ). Hypomorphic mutations in Cbc2 that weaken cap binding suppress the ∆ cs growth defect (Qiu ).Here, we show that restoration of growth of ∆ cells in the cold can also be achieved by deleting the C-terminal 77-aa segment of the essential Snp1 subunit of the U1 snRNP. Although it had been appreciated earlier that this C-terminal portion of Snp1 was dispensable for vegetative growth (Hilleren ), the genetic interactions of the Snp1-C∆ truncations were not interrogated. Underscoring the theme of redundancy in the yeastU1 snRNP, we show that otherwise benign Snp1-(1-223) and Snp1-(1-208) mutations are catastrophic in the absence of Mud2 or Nam8. Yet these same truncation alleles elicit a gain-of-function in the ∆ genetic background. Our frugal speculation is that ∆ suppression by ∆ is mediated via an effect on CBC association with the residual U1 snRNA m7G cap, whereby the C-terminal segment of Snp1 is itself a point of contact of CBC with the U1 snRNP. In this scenario, weakening of the CBC•U1 snRNP interaction by Snp1 truncation would diminish CBC association with the U1 m7G cap in ∆ cells and allow growth in the cold (more or less mimicking the Cbc2 cap-binding site mutants with respect to ∆ suppression). In cells that have TMG caps, the Cbc2 cap-binding site lesion Y24A and the Snp1-C∆ truncations, which cause no growth defects per se, synergized when combined to mimic the severe cold sensitivity of the ∆ null mutant. These findings are consistent with the idea that the Snp1 C-terminus contributes to the interaction of CBC with the U1 snRNP.The C-terminal 77-aa segment of yeastSnp1 is rich in arginine (n = 11), serine (n = 12), and alanine (n = 11) and is predicted to be strongly hydrophilic, with the exception of one hydrophobic tract (265PLLSAATPTAAVTSVY280). The amino acid sequence and composition are suggestive of structural disorder or a structure that is templated by the association of this polypeptide with other proteins. Because this segment is not conserved in humanU1-70K and the C-terminus of U1-70K is not seen in U1 snRNP crystal structures, we cannot intuit what contacts might be made by the Snp1 C-terminus. This will be an interesting topic for future studies given the broad impact, both positive and negative, of Snp1 C-terminal deletion on yeast physiology when other components of the splicing apparatus are simultaneously perturbed.In a separate approach entailing a genomic library screen, we identified as a dosage suppressor of the cold-sensitive phenotype of ∆ cells. Because even a nominally single extra copy of the gene on a CEN plasmid revived ∆ growth at 18°, we surmise that is an especially vulnerable target of the effect of the ∆ mutation. This vulnerability is unlikely to reflect a fastidious gene-specific requirement for TMG caps or other splicing factors in removing the intron, insofar as the 5′-splice site, branchpoint, and 3′-splice site adhere perfectly to the yeast consensus sequences and the intron is situated close to the 5′ end of the ORF, as is the case for most yeast genes. Rather, it is the fact that even small changes in expression can result in an overt growth defect in the cold (Nouraini ) that allowed us to recover a singularly sensitive target gene in the suppressor screen.As discussed above, we implicate ectopic binding of nuclear CBC to the m7G cap of the U1 snRNP of ∆ cells as a principal factor in the cold sensitivity of ∆ cells. Mutations in the cap-binding site of CBC or deletion of the Snp1 C-terminus completely restore normal growth of ∆ cells at 18°, unlike the dosage suppression by , which promotes growth of ∆ cells at 18°, albeit not as well as or the hypomorphic and mutations. These findings fortify the inference that the cold sensitivity of ∆ arises not from the lack of TMG caps, but from the effect of U1-bound CBC on vulnerable yeast mRNAs, among which stands out.Our studies shed new light on the structure-activity relations of Rpo26. We refine the margins of the minimal functional Rpo26 domain, identify essential side chains by alanine scanning, and interpret the mutational effects by reference to the crystal structure of Rpo26 in RNA polymerase II. Especially instructive were the mutations that separated the ∆ dosage suppression activity of Rpo26 from its globally essential function in nuclear transcription. An appealing explanation for this separation is that certain Rpo26 mutations selectively impact Rpo26 function in one (or two) of the nuclear RNA polymerases while sparing its function in the other polymerase(s) (Tan ). In that case, we infer that the , E124A, and R97A mutants, which are lethal or conditionally lethal with respect to ∆ complementation, can provide Rpo26 function for the nuclear RNA polymerase that is most affected in ∆ cells at low temperatures. That we isolated , the gene encoding the largest subunit of Pol III, in the same suppressor screen that yielded suggests to us that Pol III is especially sensitive to the level of Rpo26 subunit in ∆ cells at low temperatures. Rpo26 is in intimate contact with the large subunits of nuclear RNA polymerases during and after assembly of the polymerases (Wild and Cramer 2012) and there are well-documented genetic interactions of Rpo26 with Rpb1, the largest Pol II subunit (Archambault ; Nouraini ). We speculate that the relatively weaker suppression of ∆ by increased gene dosage (compared to suppression) reflects enhanced assembly of Pol III when Rpo26 levels are limiting.
Authors: Carlos Fernández-Tornero; María Moreno-Morcillo; Umar J Rashid; Nicholas M I Taylor; Federico M Ruiz; Tim Gruene; Pierre Legrand; Ulrich Steuerwald; Christoph W Müller Journal: Nature Date: 2013-10-23 Impact factor: 49.962